IL91128A - Pharmaceutical compositions containing 5-heteroaryl-or 5-aryl-substituted imidazo (2,1-a) isoquinolines for the prophylactic treatment of late asthma by inhalation administration - Google Patents

Pharmaceutical compositions containing 5-heteroaryl-or 5-aryl-substituted imidazo (2,1-a) isoquinolines for the prophylactic treatment of late asthma by inhalation administration

Info

Publication number
IL91128A
IL91128A IL9112889A IL9112889A IL91128A IL 91128 A IL91128 A IL 91128A IL 9112889 A IL9112889 A IL 9112889A IL 9112889 A IL9112889 A IL 9112889A IL 91128 A IL91128 A IL 91128A
Authority
IL
Israel
Prior art keywords
hydrogen
chloro
fluoro
compound
independently
Prior art date
Application number
IL9112889A
Other languages
English (en)
Other versions
IL91128A0 (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL91128A0 publication Critical patent/IL91128A0/xx
Publication of IL91128A publication Critical patent/IL91128A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
IL9112889A 1988-07-29 1989-07-27 Pharmaceutical compositions containing 5-heteroaryl-or 5-aryl-substituted imidazo (2,1-a) isoquinolines for the prophylactic treatment of late asthma by inhalation administration IL91128A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22630588A 1988-07-29 1988-07-29
US07/302,720 US4910206A (en) 1986-07-14 1989-01-27 5-hetero-or aryl-substituted-imidazo(2,1-a)isoquinolines and their use as PAF receptor antagonists

Publications (2)

Publication Number Publication Date
IL91128A0 IL91128A0 (en) 1990-03-19
IL91128A true IL91128A (en) 1996-01-31

Family

ID=26920416

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9112889A IL91128A (en) 1988-07-29 1989-07-27 Pharmaceutical compositions containing 5-heteroaryl-or 5-aryl-substituted imidazo (2,1-a) isoquinolines for the prophylactic treatment of late asthma by inhalation administration

Country Status (16)

Country Link
US (1) US4910206A (fr)
EP (1) EP0357550B1 (fr)
JP (1) JPH0273016A (fr)
KR (1) KR910002445A (fr)
AU (1) AU632487B2 (fr)
CA (1) CA1336503C (fr)
DE (1) DE68913397T2 (fr)
DK (1) DK372089A (fr)
ES (1) ES2062092T3 (fr)
FI (1) FI893616L (fr)
HU (1) HU206040B (fr)
IE (1) IE63243B1 (fr)
IL (1) IL91128A (fr)
NO (1) NO177485C (fr)
NZ (1) NZ230098A (fr)
PT (1) PT91302B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0345931B1 (fr) * 1988-04-27 1993-01-20 Schering Corporation Certains mélanges PAF antagonistes/antihistamine et procédés
US5530141A (en) * 1992-03-04 1996-06-25 Center For Innovative Technology 2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1,3-oxathiolanes; and 2,5-diaryl-1,3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5639782A (en) * 1992-03-04 1997-06-17 Center For Innovative Technology Neolignan derivatives as platelet activating factor receptor antagonists and 5-lipoxygenase inhibitors
US5648486A (en) * 1992-07-13 1997-07-15 Cytomed, Inc. Compounds and methods for the treatment of inflammatory and immune disorders
US5463083A (en) 1992-07-13 1995-10-31 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5358938A (en) * 1992-07-13 1994-10-25 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
JPH08502243A (ja) 1992-07-13 1996-03-12 サイトメッド，インコーポレイテッド 炎症性および免疫性疾患の治療のための２，５‐ジアリールテトラヒドロ‐チオフェン、‐フランおよび類似体
US5434151A (en) * 1992-08-24 1995-07-18 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5703093A (en) * 1995-05-31 1997-12-30 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5750565A (en) 1995-05-25 1998-05-12 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5792776A (en) * 1994-06-27 1998-08-11 Cytomed, Inc., Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
FR2756560A1 (fr) * 1996-12-04 1998-06-05 Adir Nouveaux derives de l'imidazoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN1076728C (zh) * 1999-02-05 2001-12-26 浙江大学 2－芳基咪唑并[2,1－a]异喹啉的衍生物及其用途
WO2021057696A1 (fr) * 2019-09-27 2021-04-01 隆泰申医药科技(南京)有限公司 Composé hétéroaryle et ses applications

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4101553A (en) * 1974-01-02 1978-07-18 Sandoz, Inc. Imidazo[2,1-a]isoquinolines
HU172649B (hu) * 1975-04-24 1978-11-28 Gyogyszerkutato Intezet Sposob poluchenija novykh biologicheski aktivnykh lizergamidov
EP0258175B1 (fr) * 1986-07-14 1992-04-01 Sandoz Ag Imidazo[2,1-a]isoquinoléines, substituées en 5 par hétéro ou aryle

Also Published As

Publication number Publication date
ES2062092T3 (es) 1994-12-16
AU3901789A (en) 1990-02-01
FI893616A7 (fi) 1990-01-30
DE68913397T2 (de) 1994-08-11
IE63243B1 (en) 1995-04-05
KR910002445A (ko) 1991-02-25
IL91128A0 (en) 1990-03-19
DK372089D0 (da) 1989-07-27
HUT50630A (en) 1990-03-28
PT91302B (pt) 1995-03-01
CA1336503C (fr) 1995-08-01
NZ230098A (en) 1992-02-25
NO177485C (no) 1995-09-27
DK372089A (da) 1990-01-30
IE892459L (en) 1990-01-29
DE68913397D1 (de) 1994-04-07
PT91302A (pt) 1990-02-08
JPH0273016A (ja) 1990-03-13
NO893062L (no) 1990-01-30
US4910206A (en) 1990-03-20
EP0357550A2 (fr) 1990-03-07
AU632487B2 (en) 1993-01-07
EP0357550B1 (fr) 1994-03-02
FI893616A0 (fi) 1989-07-28
NO893062D0 (no) 1989-07-27
FI893616L (fi) 1990-01-30
HU206040B (en) 1992-08-28
EP0357550A3 (fr) 1991-04-03
NO177485B (no) 1995-06-19

Similar Documents

Publication Publication Date Title
EP1550662B1 (fr) Compose d'adenine et son application
EP1389094B1 (fr) Administration de sedatifs hypnotiques par voie pulmonaire
AU775588B2 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
AU632487B2 (en) Improvements in or relating to organic compounds
JP2006515829A (ja) 炎症性疾病の処置のための、ａ２ａアデノシン受容体アゴニストの使用
JP2007536241A (ja) 糖尿病性腎症の処置のためのａ２ａアデノシンレセプターアゴニスト
JPH04506215A (ja) モノカイン活性干渉
EA001929B1 (ru) Способ лечения заболеваний млекопитающих и цвиттерионная композиция
CA2029704C (fr) Utilisation de derives de pyrimidone et de leurs analogues pour le traitement de l'asthme et de certaines dermatopathies
OA12660A (en) Inhalation compositions comprising tricyclic 5,6-dihydro-9H-pyrazolo(3,4-C)-1,2,4-triazolo (4,3-aopha)pyridines.
JP4783787B2 (ja) 炎症疾患を処置するためのニコチン受容体アゴニスト
TW200407153A (en) Novel combination
RU2007147595A (ru) Производные индактерола и фосфодиэстеразные ингибиторы для лечения заболеваний дыхательных путей
EP0258175B1 (fr) Imidazo[2,1-a]isoquinoléines, substituées en 5 par hétéro ou aryle
US4639445A (en) Metabolites of triazolo[1,5-c]pyrimidines
FI85481B (fi) Foerfarande foer framstaellning av 2,3 -dihydro-1-(8-metyl-1,2,4-triazolo/4,3-b/pyridazin-6-yl)-4(1h) -pyridinon.
US3743733A (en) Method of treating bronchial asthma
US4224328A (en) Methods with 1-substituted-4-aryl-quinazolin-2(1H)-ones and thiones and pyrido[2,3-d]pyrimidin-2-ones as platelet aggregation inhibitors
Spina et al. The role of platelet activating factor in allergic inflammation
HU210934B (en) Process to prepare medicaments against metastases
US20080004296A1 (en) Organic Compounds
AU637542B2 (en) Method of inhibiting activity of leukocyte derived cytokines
JPH0459776A (ja) フェノキシプロピルアミン誘導体およびこれを含有する抗潰瘍剤
HK40022828A (en) Compositions and methods for treating rheumatoid arthritis
JPS62126129A (ja) 抗アレルギ−剤

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
HC Change of name of proprietor(s)
RH Patent void